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A retrospective study was undertaken on patients with multiprimaries associated with 
vulva carcinoma, analyzing in particular 33 patients with double epidermoid primaries of the 
vulva and cervix. It is noted that 20.8% of patients with vuivar carcinoma had a second 
primary; this occurred more frequently in intraepithelial (33.3%) than in invasive (16.0%) 
vulvar carcinoma. While the commonest second primary is located in the cervix, this 
association appears significant only in patients with intraepithelial (22.5%), but not in 
invasive (7.%), vulvar carcinoma. The incidences previously reported in the literature are 
also reviewed for comparison. 
INTRODUCTION 
That epidermoid carcinoma of the vulva often is associated with a second 
primary was first noted by Taussig [l] in 1940. This relationship has subsequently 
been reported by numerous authors, with varying frequencies, both for in- 
traepithelial as well as invasive carcinoma. Abel1 [2], in 1960, suggested that a 
second primary occurred more frequently in intraepithelial than in invasive car- 
cinoma of the vulva. More specifically, a separate primary in the cervix, either 
synchronous or metachronous with that in the vulva, appears especially sig- 
nificant. Also, an appreciable number of vulvar carcinomas have been reported 
following radiotherapy for cervical carcinoma [3-51. Jimerson and Merrill [51 in 
1970 collected 132 patients with multiprimary epidermoid carcinomas involving 
both the cervix and vulva, including 15 cases of their own. As yet, however, there 
has not been an in-depth study of multiprimaries associated with vulvar car- 
cinoma. We consider it appropriate to focus attention on these issues and to 
present our experiences at the University of Michigan Hospital. Reports in the 
literature of this relationship are reviewed for the purpose of comparison. 
MATERIALS AND METHODS 
Data on all patients with multiprimaries of the female genital tract for a 20-year 
period between January 1957 and December 1977 were obtained from the Univer- 
sity of Michigan Hospital Tumor Registry. Eighty-four patients were found to 
have multiprimaries associated with the vulva; these patients were studied. Dur- 
ing this same period, 5386 patients with female genital tract cancers were treated 
at this Medical Center. This included 403 patients with epidermoid vulvar car- 
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a Ten patients had additional primary or primaries in the vagina, perineum, or anus. 
cinema, 111 of whom had intraepithelial, and 292, invasive carcinoma. Cervical 
carcinoma totaled 2800 in number. 
RESULTS 
The locations of various primaries in these 84 patients with intraepithelial and 
invasive carcinoma of the vulva are listed in Tables 1 and 2. Thus, 37 patients with 
intraepithelial, and 47 patients with invasive carcinoma of the vulva had another 
primary or primaries, representing an incidence of 33.3 and 16.0%, respectively. 
Cervical carcinoma was the most common second primary, however. This occurred 
in 25 patients with intraepithelial, and 23 patients with invasive carcinoma of the 
vulva comprising, respectively, 67.5 and 48.7% of multiprimaries in each group. 
Fifteen patients with double primaries in the cervix and vulva had additional 
primary or primaries in the vagina, perineum, and anus. The remaining 33 patients 
are presented below. 
TABLE 2 
















a Five patients had additional primary or primaries in the vulva, perineum, or anus. 
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Synchronous Primaries of the Cervix and Vulva 
Ten patients had simultaneous primaries in the cervix and vulva (Table 3). Only 
1 patient had an intraepithelial lesion in both locations, while the rest had 
intraepithelial-invasive combinations. Their age disparity is also evident (Table 
3). 
The presenting symptom varied. Of 6 patients with intraepithelial carcinoma of 
the vulva and invasive carcinoma of the cervix, 2 presented with pruritus vulva, 2 
with vaginal bleeding, 1 with vaginal discharge, and the sixth was asymptomatic. 
Of 3 patients with invasive carcinoma of the vulva and in situ carcinoma of the 
cervix, 2 complained of a vulvar swelling, and 1, vaginal bleeding. The patient 
with simultaneous intraepithelial disease of the cervix and the vulva was 
asymptomatic. 
All patients with carcinoma of the vulva, whether intraepithelial or invasive, had 
visible lesions. These were variously described as: leukoplakia, ulcer, mass, red, 
or granular lesions. On the contrary, three of four patients with in situ carcinoma 
of the cervix had no abnormal findings; the diagnosis in all was made following an 
abnormal cervical smear. Among six patients with invasive carcinoma of the 
cervix, biopsy of a suspicious lesion in five yielded a diagnosis. The sixth patient 
underwent a diagnostic conization for an abnormal cervical cytology, this showed 
carcinoma in situ; however, following a total abdominal hysterectomy and bilat- 
eral salpingo-oophorectomy, a focus of invasive cervical squamous carcinoma 
was found. 
With the exception of a stage IIIB cervical carcinoma, the invasive primary of 
the vulva or the cervix in these patients was in stage I. 
Of 6 patients with invasive cervical carcinoma and intraepithelial vulvar dis- 
ease, 4 received radiotherapy for the cervical lesion and surgery, ranging from 
wide local excision to radical vulvectomy, for the vulvar disease. One patient 
with stage IIIB cervical carcinoma died of metastases to the brain while undergo- 
ing radiation. The sixth patient underwent trachelectomy for a stage IA cervical 
carcinoma and simultaneous radical vulvectomy for intraepithelial vulvar disease; 
she however died of postoperative sepsis and acute renal failure. Of 3 patients 
with invasive vulvar and intraepithelial cervical carcinoma, 1 was treated with 
only a hemivulvectomy because of her advanced age, while her cervical lesion 
was followed. She died 9 years later from a myocardial infarction. Two patients 
were treated sequentially with a radical vulvectomy and groin lymphadenectomy 
followed by a total abdominal hysterectomy and bilateral salpingo-oophorectomy. 
The patient with double intraepithelial carcinoma of the cervix and vulva under- 
TABLE 3 
SVNCHR~N~~~D~VBLEPRIMARIESOFTHECERVIXANDTHEVVLVA 
Vulvar carcinoma Cervical carcinoma 
No. of Median age 
patients (years) 
In situ Invasive 6 58 
Invasive In situ 3 57 
In situ In situ 1 24 
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went therapeutic conization as well as a wide excision of her vulvar lesion. In all, 7 
patients are alive without disease 1 to 29 years after treatment. 
Metachronous Primaries of Cervix and Vulva 
There are 23 patients in this group as shown in Table 4. Significantly the initial 
primary is cervical in all but 1 patient. Of the 12 patients with an initial invasive 
cervical primary, 6 developed an intraepithelial and 6, invasive vulvar carcinoma 
after a mean interval of 10 and 17.3 years respectively. It is noteworthy that 10 
among them had prior radiation treatment for cervical cancer. 
The stages of the initial invasive cervical carcinoma in these 12 patients in- 
cluded 7 stage I and 1 stage II disease. The remaining 4 received treatment 
elsewhere and had no detailed information available. Of the 6 patients who 
subsequently developed an invasive primary in the vulva, 5 had stage I and 1 had 
stage IV disease. 
Four of the six patients with sequential invasive, cervical, and vulvar carcinoma 
underwent radical vulvectomy and bilateral groin lymphadenectomy for their 
vulvar disease. Two of them died-one from postoperative renal failure and the 
other from recurrent metastatic vulvar disease. One had local recurrence, a 
planned exenteration was abandoned on finding positive iliac nodes; she sub- 
sequently received further radiation to the pelvis, groins and perineum and is well 
2 years later. The fifth patient refused either surgery or radiotherapy, and is alive 
with disease 1 year after diagnosis. The sixth patient died of an advanced stage IV 
vulvar disease 1 year after chemotherapy. 
In six patients with subsequent intraepithelial vulvar carcinoma following an 
invasive cervical carcinoma, surgery ranging from conservative wide local exci- 
sion to radical vulvectomy was performed. Five are without disease from 6-9 
years. One went on to develop a third primary in the esophagus 3 years later and 
succumbed to it. 
Nine patients had sequential intraepithelial carcinoma involving the cervix and 
then the vulva. These patients were relatively young with a mean age of 30.2 at 
initial diagnosis and progressed to develop a second primary at a relatively short 
interval averaging 4 years. Conservative treatment was the rule in these patients. 
Wide local excision of vulvar lesion was performed in 6 patients, subtotal vulvec- 
tomy in 2, and local 5 FU therapy in 1. All are without disease from 2 to 25 years. 
One patient developed an invasive vulvar carcinoma 20 years after an initial 
TABLE 4 
METACHRONOUS DOUBLE PRIMARIES OF THE CERVIX AND THE VULVA 





Invasive Ca, cervix 
Invasive Ca, cervix 
In situ Ca, cervix 
In situ Ca, cervix 
Invasive Ca, vulva 
Invasive Ca, vulva 
In situ Ca, vulva 
In situ Ca, vulva 
Invasive Ca, vulva 
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intraepithelial carcinoma in the cervix. She died 5 years after a radical vulvectomy 
and groin lymphadenectomy from a myocardial infarction. 
The only patient who had a preceding invasive vulvar carcinoma acquired an 
intraepithelial carcinoma of the cervix 8 years after radical vulvectomy and groin 
lymphadenectomy. A total abdominal hysterectomy and bilateral salpingo- 
oophorectomy were performed and she is alive 18 years later. 
DISCUSSION 
The incidence of multiple primary neoplasms in the general population 
has been reported to vary from less than 1% [6] to 11% [7], but averages 3-5% 
in most clinical and autopsy series. Moertel showed that multicentric multipri- 
mary neoplasms tend to occur more frequently in the same tissues and organs, 
and in bilaterally paired organs. Multiprimaries in nonidentical tissues or organs, 
on the other hand, showed no statistical increase in frequency. These occur, 
rather, by chance related to age, longevity, and cure of the initial primary [8,9]. 
The entire lower genital tract, including the anus and the perineum, are em- 
bryologically interrelated. It is postulated that a common carcinogen may affect 
the unique epithelial field of this region in a manner resulting in simultaneous or 
sequential development of neoplasms [4,10]. A viral carcinogen may be operative, 
and implicated are HSV II [ 11,121, as well as condyloma accumulata viruses [ 131. 
A venereal route may explain the high frequency of involvement of the cervix and 
vulva, both being the commonest neoplasms of the lower genital tract. 
Since the previous reviews by Hansen and Collins in 1967 [14], and Jimerson 
and Merrill in 1970 [5], there have been continual reports of double primaries of 
the cervix and vulva. An update of these cases brings the total number to 285 
(Table 5). 
The reported incidence of a second primary in patients with vulvar carcinoma 
ranges widely from 1.5% [25] to 37.5% [2]. An overall incidence of 20.8% is found 
TABLE 5 
REPORTED CASES OF DOUBLE PRIMARIES OF THE CERVIX AND THE VULVA 
Author No. of cases Prior radiation 
Jimerson and Merrill [5], 1970 
Collins [15], 1970 
Hughes [16], 1971 
Boutselis [17], 1972 
Boutselis [18], 1972 
Charles [19], 1972 
Kelly [20], 1972 
Franklin [ 111, 1972 
Woodruff [ 131, 1973 
Dean [21], 1974 
Parker [22], 1975 
Japaze [23], 1976 
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TABLE 6 
REPORTED INCIDENCE OF SECOND PRIMARY IN INTRAEPITHELIAL CARCINOMA OF THE VULVA 
Abell [2], 1961 
Boutselis [17], 1972 








in our series. This occurred more frequently in patients with intraepithelial 
(33.5%) than with invasive carcinoma (16.0%), and is in concurrence with most 
reported incidences (Tables 6 and 7). In our series, nongenital second primaries 
comprise an incidence of 9.0 and 6.9%, respectively, in patients with intraepithe- 
lial and invasive carcinomas of the vulva. These values are not significantly higher 
than the reported incidence of multiprimary neoplasms in the general population. 
More important, however, is the occurrence of a cervical primary in patients with 
vulvar carcinoma. Our findings indicate that this association is significant in 
patients with intraepithelial (22.5%) but not with invasive vulvar carcinoma 
(7.9%). The reported incidence of cervical carcinoma in patients with intraepithe- 
lial and invasive carcinomas of the vulva are presented for comparison in Tables 8 
and 9. Where reports in both groups by the same author are available, our findings 
are in agreement with that of Boutselis [ 17,181 and Japaze [23], but at variance 
with that of Merrill [31]. 
The significant association of cervical neoplasm with intraepithelial vulvar 
carcinoma should be borne in mind. Lately, intraepithelial carcinoma of the vulva 
has been reported to increase in frequency [ 13, 15, 17, 23, 30, 3 11, afflicting more 
young females than before [23]; some have noted an absolute increase in relation- 
ship to its invasive counterpart [ 15, 17,3 1,321 suggesting perhaps a changing trend 
in this disease. This apparent increase may also result from increased awareness 
by both physicians and patients, as well as freer use of biopsies diagnosing more 
cases in the preinvasive state. 
In invasive double primaries of common epithelial origin as in the cervix and the 
vulva, differentiation from metastases is important. Warren and Gates laid down 
criteria for multiprimaries that are generally accepted: that each of the tumors be 
TABLE 7 
REPORTED INCIDENCE OF SECOND PRIMARY IN INVASIVE CARCXNOMA OF THE VULVA 
Taussig [ 11, 1940 6.4% 
Green [26], 1958 13.4% 
Gosling [25], 1961 1.5% 
Collins [27], 1963 15.6% 
Shingleton [28], 1970 15.0% 
Cavanagh [29], 1970 5.0% 
Boutselis [IS], 1972 15.0% 
Parker [22], 1975 22.0% 
Japaze [23], 1977 14.0% 
Present series 16.0% 
Average 13.3% 
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TABLE 8 
REPORTED INCIDENCE OF CERVICAL NEOPLASM IN INTRAEPITHELIAL CARCINOMA OF THE VULVA 
Hansen [14], 1967 25.0% 
Rutledge [303, 1968 26.8% 
Boutselis [17], 1972 16.7% 
Merrill [31], 1973 55.5% 
Japaze [23], 1977 28.2% 
’ Present series 22.5% 
Average 29.1% 
present with definite pictures of malignancy, that each be distinct, and that the 
probability of one being a metastasis of the other be excluded [33]. In our series, 
metastatic carcinoma of the cervix to the vulva has been excluded, and simultane- 
ous invasive carcinoma of the cervix and vulva is conspicuously absent. Although 
there were six patients with invasive cervical carcinoma who subsequently de- 
veloped an invasive vulvar cancer, their mean interval was 17.3 years. 
It is noteworthy that of the 12 patients who developed a vulvar primary sub- 
sequent to an invasive cervical cancer, 10 received prior radiation, with a mean 
interval of 17.5 years. There is undoubtedly a strong implication of radiation 
carcinogenicity in our series. Approximately one-third of our patients with double 
primaries of cervix and vulva had prior radiation for cervical carcinoma. This also 
has been the experience of Collins [ 151, Woodruff [ 131, and Figge [3]. Of 285 
patients with double primaries of the cervix and vulva reported to date, 45 had 
prior radiotherapy for cervical cancer (Table 6). The vulvar skin is known to be 
low in radiotolerance; this perhaps is attributable to the warmth and moisture in 
this area, as well as the blood supply to the skin being derived from end arteries. 
Although the vulvar skin is excluded from the portals of radiation treatment for 
cervical carcinoma, it nevertheless receives approximately 5% of scattered exter- 
nal radiation, and a much higher dose is contributed by the sources in the 
tandem-ovoid system. The relationship between the given dose and the dose 
received by the vulva cannot be estimated from our series. It has been known that 
radiation-induced carcinoma of the skin may occur following chronic exposure 
[34], or from an area of radiodermatitis [35]. Thus, possibly the delicate vulvar 
skin is sensitive to radiation carcinogenicity, or radiation itself potentiates 
preexisting local carcinogens in the vulva. 
Awareness of a possible double primary in the cervix and vulva is the keystone 
to the diagnosis of these related entities. Three of our nine patients with syn- 
TABLE 9 
REPORTED INCIDENCE OF CERVICAL NEOPLASM IN INVASIVE CARCINOMA OF THE VULVA 
Boutselis [18], 1972 
Merrill [31], 1973 
Dean [21]. 1974 
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chronous primaries probably failed to have their intraepithelial vulvar lesions 
detected until radiation treatment was begun. Such patients may present with a 
symptom referable to either location, or they may be entirely asymptomatic. 
Premalignant lesions of the cervix often arouse suspicion initially from an abnor- 
mal cervical smear, and the majority of such patients will reveal no gross findings 
in the cervix. On the contrary, in vulvar carcinoma, whether intraepithelial or 
invasive, a lesion is invariably present. It thus cannot be overemphasized that a 
meticulous visual examination of the external genitalia, coupled with a liberal 
biopsy of any suspicious areas, is the only means of detecting its lesions. To- 
luidine blue staining of the vulva may not be reliable as areas of fissures, cracks, 
and abrasions retain dyes, and a false positive rate of 17% has been reported [36]. 
To avoid this error, a colposcope could be used before and after staining [37]. 
In the case of the cervix, Schiller staining may be equally inaccurate [38]. In 
experienced hands, the colposcope should be a highly reliable and accurate tool in 
evaluating and screening the entire lower genital tract for preinvasive and invasive 
diseases. 
Our series also indicates that in patients with invasive vulvar carcinoma, exten- 
sive workup, other than that essential for staging purposes, on the pretext of 
diagnosing associated nongenital primaries is not warranted. 
The presence of a vulvar primary should always arouse suspicion of a possible 
simultaneous primary in the cervix. Whereas in metachronous primaries of the 
cervix and vulva the initial primary is invariably cervical; thus in the followup of 
patients with cervical carcinoma, one should be on the lookout for a possible new 
primary in the vulva. 
Not uncommonly, an additional primary may also occur in the vagina, 
perineum, or anus. This rightly is so, since the entire region is at risk for multicen- 
tric multiprimaries. 
The treatment modality is as conventional as for the individual neoplasm alone. 
In preinvasive lesions, conservative treatment can and should be employed, 
especially in younger patients, provided an adequate clear margin of resection can 
be obtained. Mapping techniques using staining methods and/or colposcopy can 
be utilized. In the presence of simultaneous invasive cervical and vulvar car- 
cinoma, if radiation is contemplated for the cervical lesion, treatment of the vulvar 
lesion should probably take precedence over that of cervical cancer so as to avoid 
morbid sequelae of compromised wound healing. Premalignant lesions are curable 
by conservative methods, and, if they recur, can be retreated. The presence of 
double primaries in the cervix and vulva does not appear to adversely affect 
prognosis or survival. 
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